Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Buys 50,000 Shares

Share on StockTwits

Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost bought 50,000 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were bought at an average cost of $1.56 per share, with a total value of $78,000.00. Following the transaction, the chief executive officer now directly owns 3,068,951 shares of the company’s stock, valued at $4,787,563.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Phillip Md Et Al Frost also recently made the following trade(s):

  • On Tuesday, November 26th, Phillip Md Et Al Frost purchased 100,000 shares of Opko Health stock. The shares were bought at an average price of $1.55 per share, for a total transaction of $155,000.00.
  • On Monday, November 18th, Phillip Md Et Al Frost purchased 100,000 shares of Opko Health stock. The stock was purchased at an average cost of $1.48 per share, for a total transaction of $148,000.00.
  • On Tuesday, November 12th, Phillip Md Et Al Frost acquired 200,000 shares of Opko Health stock. The stock was purchased at an average price of $1.44 per share, with a total value of $288,000.00.
  • On Friday, November 8th, Phillip Md Et Al Frost acquired 50,000 shares of Opko Health stock. The shares were purchased at an average cost of $1.48 per share, with a total value of $74,000.00.
  • On Wednesday, November 6th, Phillip Md Et Al Frost acquired 350,000 shares of Opko Health stock. The shares were purchased at an average cost of $1.49 per share, with a total value of $521,500.00.
  • On Thursday, October 31st, Phillip Md Et Al Frost bought 50,000 shares of Opko Health stock. The stock was purchased at an average price of $1.43 per share, for a total transaction of $71,500.00.
  • On Tuesday, October 29th, Phillip Md Et Al Frost bought 200,000 shares of Opko Health stock. The stock was purchased at an average price of $1.47 per share, for a total transaction of $294,000.00.
  • On Friday, October 25th, Phillip Md Et Al Frost bought 2,000,000 shares of Opko Health stock. The stock was purchased at an average price of $1.50 per share, for a total transaction of $3,000,000.00.

Shares of Opko Health stock traded down $0.01 during midday trading on Tuesday, hitting $1.55. The company had a trading volume of 29,292 shares, compared to its average volume of 4,960,268. The business’s 50 day simple moving average is $1.64 and its two-hundred day simple moving average is $1.93. The stock has a market cap of $1.04 billion, a PE ratio of -6.24 and a beta of 2.20. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.08 and a quick ratio of 0.90. Opko Health Inc. has a 1-year low of $1.33 and a 1-year high of $3.93.

Opko Health (NASDAQ:OPK) last issued its quarterly earnings results on Tuesday, November 5th. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by ($0.02). The firm had revenue of $228.80 million for the quarter, compared to the consensus estimate of $225.40 million. Opko Health had a negative net margin of 30.98% and a negative return on equity of 14.42%. The company’s revenue was down 8.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.05) earnings per share. On average, sell-side analysts expect that Opko Health Inc. will post -0.43 EPS for the current fiscal year.

Hedge funds have recently made changes to their positions in the stock. Alpha Cubed Investments LLC acquired a new position in Opko Health during the 3rd quarter worth about $25,000. Eqis Capital Management Inc. bought a new stake in Opko Health in the second quarter valued at approximately $33,000. Sawtooth Solutions LLC acquired a new stake in Opko Health in the second quarter worth $45,000. Kings Point Capital Management acquired a new stake in Opko Health in the second quarter worth $45,000. Finally, GABELLI & Co INVESTMENT ADVISERS INC. boosted its position in shares of Opko Health by 100.0% during the second quarter. GABELLI & Co INVESTMENT ADVISERS INC. now owns 20,000 shares of the biotechnology company’s stock worth $49,000 after purchasing an additional 10,000 shares in the last quarter. 21.61% of the stock is owned by hedge funds and other institutional investors.

A number of equities research analysts have issued reports on OPK shares. Barrington Research restated a “buy” rating and set a $4.00 price target on shares of Opko Health in a report on Thursday, September 12th. BidaskClub upgraded Opko Health from a “sell” rating to a “hold” rating in a research note on Thursday, November 21st. Zacks Investment Research raised Opko Health from a “hold” rating to a “buy” rating and set a $2.00 price objective for the company in a research report on Friday, October 18th. Finally, Piper Jaffray Companies began coverage on Opko Health in a research note on Monday, November 25th. They set an “overweight” rating and a $2.50 target price for the company. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Opko Health currently has a consensus rating of “Buy” and a consensus price target of $2.83.

Opko Health Company Profile

OPKO Health, Inc, a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services.

Further Reading: Insider Trading – What You Need to Know

Insider Buying and Selling by Quarter for Opko Health (NASDAQ:OPK)

Receive News & Ratings for Opko Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.